Qing-Jie Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qing-Jie Liu has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
Xue Lu
China CDC Key Laboratory of Radiological Protection and Nuclear Emergency, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention
16 shared publicationsMei Tian
Chinese Center for Disease Control and Prevention, China CDC Key Laboratory of Radiological Protection and Nuclear Emergency, National Institute for Radiological Protection, Beijing, PR China
15 shared publicationsTian-Jing Cai
China CDC Key Laboratory of Radiological Protection and Nuclear Emergency, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention
13 shared publicationsShuang Li
China CDC Key Laboratory of Radiological Protection and Nuclear Emergency, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention
10 shared publicationsHai-Xiang Liu
China CDC Key Laboratory of Radiological Protection and Nuclear Emergency, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing, P.R. China
7 shared publicationsHua Zhao
China CDC Key Laboratory of Radiological Protection and Nuclear Emergency, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention
7 shared publications
Latest Publications
- 12 November 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1959
Role of Non-coding RNAs in radiation-induced digestive injury
- 12 November 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1959
Role of Non-coding RNAs in radiation-induced digestive injury
- 5 October 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- p. 1-11
Screening of early radiation-responsive long non-coding RNAs in human lymphoblastoid cells AHH-1 and a preliminary investigation of their potential for biodosimetry
Nuclear and radiation technologies are widely applied in multiple fields, including military, medicine, industry and agriculture. Although large-scale events remain rare, they pose substantial publ...
- 5 October 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- p. 1-11
Screening of early radiation-responsive long non-coding RNAs in human lymphoblastoid cells AHH-1 and a preliminary investigation of their potential for biodosimetry
Nuclear and radiation technologies are widely applied in multiple fields, including military, medicine, industry and agriculture. Although large-scale events remain rare, they pose substantial publ...
- 1 September 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- p. 1-19
Intestinal stem cells in radiation-induced intestinal injury: mechanisms and therapeutic targets
- 1 September 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- p. 1-19
Intestinal stem cells in radiation-induced intestinal injury: mechanisms and therapeutic targets
- 3 April 2026
- Published by Taylor & Francis in Biomarkers
- Vol. 31 (6) , 1-15
Identification of Mrm2 as a Key Regulator in Mitochondrial Dysfunction During Radiation-Induced Intestinal Injury
Radiation-induced intestinal injury (RIII) is a serious complication of radiotherapy and is closely related to mitochondrial dysfunction, yet its mechanism remains unclear. In this study, a series of mitochondrial-related differentially expressed genes were identified in the RIII model, whose core functional modules include mitochondrial-coding genes and apoptosis-related genes. Histopathological staining analysis indicated that RIII shows a significant dose- and time-dependent aggravation. Experiments showed Mrm2 was continuously upregulated after irradiation in vivo. Mrm2 may serve as a key regulatory factor for mitochondrial dysfunction in RIII.
- 3 April 2026
- Published by Taylor & Francis in Biomarkers
- Vol. 31 (6) , 1-15
Identification of Mrm2 as a Key Regulator in Mitochondrial Dysfunction During Radiation-Induced Intestinal Injury
Radiation-induced intestinal injury (RIII) is a serious complication of radiotherapy and is closely related to mitochondrial dysfunction, yet its mechanism remains unclear. In this study, a series of mitochondrial-related differentially expressed genes were identified in the RIII model, whose core functional modules include mitochondrial-coding genes and apoptosis-related genes. Histopathological staining analysis indicated that RIII shows a significant dose- and time-dependent aggravation. Experiments showed Mrm2 was continuously upregulated after irradiation in vivo. Mrm2 may serve as a key regulatory factor for mitochondrial dysfunction in RIII.
- 19 March 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (8) , 1-13
Improved gene expression biodosimetry for dose estimation using an expanded panel of radiation-responsive genes
The extensive application of nuclear technology across diverse fields such as national defense, nuclear power plant, and medicine significantly increases the probability of nuclear and radiological...
- 19 March 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (8) , 1-13
Improved gene expression biodosimetry for dose estimation using an expanded panel of radiation-responsive genes
The extensive application of nuclear technology across diverse fields such as national defense, nuclear power plant, and medicine significantly increases the probability of nuclear and radiological...
- 25 February 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (5) , 435-446
Mitochondrial function-related genes and ionizing radiation-induced intestinal injury: mechanisms and research progress
- 25 February 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (5) , 435-446
Mitochondrial function-related genes and ionizing radiation-induced intestinal injury: mechanisms and research progress
- 11 December 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (3) , 205-215
Role of programmed cell death in radiation-induced intestinal injury
Radiation-induced intestinal injury (RIII) is a common complication after radiotherapy for abdominal and pelvic tumors, which seriously affects the prognosis and treatment outcome of patients, and lacks effective prevention and treatment methods. The primary pathological manifestations of RIII are the death of intestinal epithelial cells, as well as the destruction of the intestinal mechanical barrier's integrity, which is closely related to various kinds of programmed cell death (PCD). In addition, radiation-induced DNA double-strand breaks can trigger a variety of PCDs. Elucidating how different PCD pathways regulate RIII molecular mechanisms and identifying the key therapeutic targets will provide the theoretical foundation for developing RIII prevention and treatment strategies. This review systematically expounds the role of PCD in the pathogenesis of RIII and summarizes the relevant small molecule drugs currently under research. PCD plays a central role in the occurrence and development of RIII. Analyzing single pathways and elucidating the 'cross-talk' and regulatory logic between different forms of PCD, as well as identifying key molecular targets located at the intersection of multiple pathways, is likely to become a more effective new direction for prevention and treatment.
- 11 December 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (3) , 205-215
Role of programmed cell death in radiation-induced intestinal injury
Radiation-induced intestinal injury (RIII) is a common complication after radiotherapy for abdominal and pelvic tumors, which seriously affects the prognosis and treatment outcome of patients, and lacks effective prevention and treatment methods. The primary pathological manifestations of RIII are the death of intestinal epithelial cells, as well as the destruction of the intestinal mechanical barrier's integrity, which is closely related to various kinds of programmed cell death (PCD). In addition, radiation-induced DNA double-strand breaks can trigger a variety of PCDs. Elucidating how different PCD pathways regulate RIII molecular mechanisms and identifying the key therapeutic targets will provide the theoretical foundation for developing RIII prevention and treatment strategies. This review systematically expounds the role of PCD in the pathogenesis of RIII and summarizes the relevant small molecule drugs currently under research. PCD plays a central role in the occurrence and development of RIII. Analyzing single pathways and elucidating the 'cross-talk' and regulatory logic between different forms of PCD, as well as identifying key molecular targets located at the intersection of multiple pathways, is likely to become a more effective new direction for prevention and treatment.
- Open Access
- 1 September 2025
- Published by Beijing Zhonghui Traditional Chinese Medicine Journal Co., Ltd in World Journal of Integrated traditional and western Medicine(WJIM)
- Vol. 11 (3) , 207-210
Cannabidiol: Rescuing hematopoietic stem cells from radiation-induced injury
世界中西医结合杂志(英文版) World Journal of Integrated traditional and western Medicine sensitive to elevated ROS, causing persisted hematopoietic failure which could be lethal. The discovery of antioxidant medicine for radiation-induced bone marrow injury, acting as the defensive Qi, is of great importance. CBD is the main representatives of plant cannabinoids and plays important roles in anti-inflammatory, analgesic, osteoporosis and cancer treatment [ 4 ]. An overall
- 1 September 2025
- Published by Beijing Zhonghui Traditional Chinese Medicine Journal Co., Ltd in World Journal of Integrated traditional and western Medicine(WJIM)
- Vol. 11 (3) , 207-210
Open AccessCannabidiol: Rescuing hematopoietic stem cells from radiation-induced injury
世界中西医结合杂志(英文版) World Journal of Integrated traditional and western Medicine sensitive to elevated ROS, causing persisted hematopoietic failure which could be lethal. The discovery of antioxidant medicine for radiation-induced bone marrow injury, acting as the defensive Qi, is of great importance. CBD is the main representatives of plant cannabinoids and plays important roles in anti-inflammatory, analgesic, osteoporosis and cancer treatment [ 4 ]. An overall
- 28 April 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 101 (6) , 590-597
Establishment and verification of the dose-effect curve of dicentric chromosomes by semi-automatic analysis of human peripheral blood irradiated by X-ray in vitro
To establish and validate a dose-response curve for dicentric chromosomes (DC) induced by X-rays in human peripheral blood in vitro using semi-automated scoring. Peripheral blood samples were collected from three healthy individuals and exposed to X-ray doses of 0, 0.25, 0.5, 0.75, 1, 2, 3, 4, and 5 Gy at a dose rate of 1.158 Gy/min. Dicentric chromosomes in metaphase were scored both full- and semi-automatically, and a dose-response curve was generated with CABAS software based on dicentric yields. Dose estimations were then performed for 12 biodosimetry standard samples and one sample from a patient with X-ray-induced skin injury. Dicentric yields increased with X-ray doses from 0 to 5 Gy (r = 0.943, P < 0.01). The dose-response association followed a linear-quadratic model: Y = 0.0002 (± 0.0001) + 0.0379 (± 0.0032) × D + 0.0253 (± 0.0014) × D2 (R2 = 0.998, P < 0.01), where Y represents dicentric yields and D is the dose. The estimated dose for 12 validation samples aligned closely with actual doses. The estimated whole-body average absorbed dose for the patient was 0.73 Gy, with observed DC over-dispersion suggesting partial body exposure. By using the Dolphin model, this dose was refined to 2.22 Gy and estimated irradiated body volume was 35.94%, consistent with clinical diagnosis. The dose-response curve developed using semi-automated scoring offer a reliable and efficient approach for dose estimation and clinical diagnosis in nuclear radiation emergencies. It could also support retrospective biodosimetry of partial-body, non-uniform radiation exposure.
- 28 April 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 101 (6) , 590-597
Establishment and verification of the dose-effect curve of dicentric chromosomes by semi-automatic analysis of human peripheral blood irradiated by X-ray in vitro
To establish and validate a dose-response curve for dicentric chromosomes (DC) induced by X-rays in human peripheral blood in vitro using semi-automated scoring. Peripheral blood samples were collected from three healthy individuals and exposed to X-ray doses of 0, 0.25, 0.5, 0.75, 1, 2, 3, 4, and 5 Gy at a dose rate of 1.158 Gy/min. Dicentric chromosomes in metaphase were scored both full- and semi-automatically, and a dose-response curve was generated with CABAS software based on dicentric yields. Dose estimations were then performed for 12 biodosimetry standard samples and one sample from a patient with X-ray-induced skin injury. Dicentric yields increased with X-ray doses from 0 to 5 Gy (r = 0.943, P < 0.01). The dose-response association followed a linear-quadratic model: Y = 0.0002 (± 0.0001) + 0.0379 (± 0.0032) × D + 0.0253 (± 0.0014) × D2 (R2 = 0.998, P < 0.01), where Y represents dicentric yields and D is the dose. The estimated dose for 12 validation samples aligned closely with actual doses. The estimated whole-body average absorbed dose for the patient was 0.73 Gy, with observed DC over-dispersion suggesting partial body exposure. By using the Dolphin model, this dose was refined to 2.22 Gy and estimated irradiated body volume was 35.94%, consistent with clinical diagnosis. The dose-response curve developed using semi-automated scoring offer a reliable and efficient approach for dose estimation and clinical diagnosis in nuclear radiation emergencies. It could also support retrospective biodosimetry of partial-body, non-uniform radiation exposure.
- 13 August 2024
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 100 (10) , 1481-1492
Targeted lipidomics-based study of radiation-induced metabolite profiles changes in plasma of total body irradiation cases
PurposeLipidomics is an important tool for triaging exposed individuals, and helps early adoption of prevention and control strategies. The purpose of this study was to screen significantly perturbed lipids between pre- and post-irradiation of human plasma samples after total body irradiation (TBI) and explore potential radiation biomarkers for early radiation classification.MethodsPlasma samples were collected before and after irradiation from 22 hospitalized cases of acute myeloid leukemia (AML) prepared for bone marrow transplantation. Acute total-body gamma irradiation was performed at doses of 0, 4, 8, and 12 Gy. Ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) with multiple reaction monitoring (MRM) method was utilized. Self-paired studies before and after irradiation were performed to screen potential lipid categorization markers and markers of dose-response relationships for radiation perturbation in humans. Based on the screened potential markers, a human TBI dose estimation model was developed.ResultsIn total, 426 individual lipids from 14 major classes were quantified and 152 potential biomarkers with categorical characteristics were screened. A total of 80 lipids (32 TGs, 29 SMs, 9 FAs, 5 CEs, 5 PIs) were upregulated at 4 Gy, and a total of 91 lipids (39 SMs, 18 TGs, 15 HexCers, 7 CEs, 6 Cers, 3 LacCers, 2 LPEs, 1 PI) were upregulated at 12 Gy. Comparison of the ROC curves between the non-exposed and exposed groups at different doses showed AUC values ranging from 0.807 to 0.876. The metabolic pathways of potential lipid markers are mainly sphingolipid and glycerolipid metabolism, unsaturated fatty acid biosynthesis, fatty acid degradation and biosynthesis. Among the 13 dose-dependent radiosensitive lipids, CE (20:5), CE (18:1) and PI (18:2/18:2) were gradually incorporated into the TBI dose estimation model.ConclusionThis study suggested that it was feasible to acquire quantitative lipid biomarker panels using targeted lipidomics platforms for rapid, high-throughput triage. Lipidomics strategies for radiation biodosimetry in humans were established with lipid biomarkers with good dose-response relationship.
- 13 August 2024
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 100 (10) , 1481-1492
Targeted lipidomics-based study of radiation-induced metabolite profiles changes in plasma of total body irradiation cases
PurposeLipidomics is an important tool for triaging exposed individuals, and helps early adoption of prevention and control strategies. The purpose of this study was to screen significantly perturbed lipids between pre- and post-irradiation of human plasma samples after total body irradiation (TBI) and explore potential radiation biomarkers for early radiation classification.MethodsPlasma samples were collected before and after irradiation from 22 hospitalized cases of acute myeloid leukemia (AML) prepared for bone marrow transplantation. Acute total-body gamma irradiation was performed at doses of 0, 4, 8, and 12 Gy. Ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) with multiple reaction monitoring (MRM) method was utilized. Self-paired studies before and after irradiation were performed to screen potential lipid categorization markers and markers of dose-response relationships for radiation perturbation in humans. Based on the screened potential markers, a human TBI dose estimation model was developed.ResultsIn total, 426 individual lipids from 14 major classes were quantified and 152 potential biomarkers with categorical characteristics were screened. A total of 80 lipids (32 TGs, 29 SMs, 9 FAs, 5 CEs, 5 PIs) were upregulated at 4 Gy, and a total of 91 lipids (39 SMs, 18 TGs, 15 HexCers, 7 CEs, 6 Cers, 3 LacCers, 2 LPEs, 1 PI) were upregulated at 12 Gy. Comparison of the ROC curves between the non-exposed and exposed groups at different doses showed AUC values ranging from 0.807 to 0.876. The metabolic pathways of potential lipid markers are mainly sphingolipid and glycerolipid metabolism, unsaturated fatty acid biosynthesis, fatty acid degradation and biosynthesis. Among the 13 dose-dependent radiosensitive lipids, CE (20:5), CE (18:1) and PI (18:2/18:2) were gradually incorporated into the TBI dose estimation model.ConclusionThis study suggested that it was feasible to acquire quantitative lipid biomarker panels using targeted lipidomics platforms for rapid, high-throughput triage. Lipidomics strategies for radiation biodosimetry in humans were established with lipid biomarkers with good dose-response relationship.